close

Enter

Log in using OpenID

Global Hormone Replacement Therapy Market 2015-2019

embed
An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy, by route of administration, and by geography. The report also presents the vendor landscape and a corresponding detailed analysis of the
Global Hormone Replacement Therapy Market 2015-2019
Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type
of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and
APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top
vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and
Pfizer.
Request for sample copy of this report at: http://www.orbisresearch.com/contacts/requestsample/204243
An overview of the hormone replacement therapy market
Hormone replacement therapy involves the replacement of the hormones in the body whose levels have
become low, in case of women nearing menopause or patient with growth hormone deficiency due to
conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which
are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major
drivers influencing the growth of the market. Therefore, the need for new treatment options with better
safety results to accommodate the current unmet need is huge.
In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and
this trend is expected to continue during the forecast period. However, the market in the APAC region is
witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region.
Technavio expects the global hormone replacement therapy market to grow at a moderate rate, posting a
CAGR of over 2% during the forecast period.
Read more details of the report at: http://www.orbisresearch.com/reports/index/global-hormonereplacement-therapy-market-2015-2019
Segmentation of the hormone replacement therapy market by type of hormonal therapy


Estrogen replacement therapy
Growth hormone replacement therapy
With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone
replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen
hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term
changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.
Segmentation of the hormone replacement therapy market by route of administration



Oral
Parenteral
Transdermal
The oral route of administration is a sub-division of enteral administration and is regarded as one of the
safest and most preferred routes of drug administration. Some of the drug that are administered orally
are Premarin and Estrace.
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Competitive landscape and key vendors
The global hormone replacement therapy market is a mature market, which is extremely competitive
due to the presence of a huge number of small and large vendors. Therefore, development of low-dose
oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected
to captivate the attention of players in the hormonal replacement market.
Key vendors in this market are 




F. Hoffmann-La Roche
Merck Serono
Novartis
Novo Nordisk
Pfizer
Enquire more about the report at: http://www.orbisresearch.com/contact/purchase/204243
Other prominent vendors included in this report are Abbott Laboratories, Amgen, ANI Pharmaceuticals,
Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion, QuatRx
Pharmaceuticals, Teva Pharmaceutical Industries, and TherapeuticsMD.
Key questions answered in the report include








What will the market size and the growth rate be in 2019?
What are the key factors driving the global hormone replacement therapy market?
What are the key market trends impacting the growth of the global hormone replacement
therapy market?
What are the challenges to market growth?
Who are the key vendors in the global hormone replacement therapy market?
What are the market opportunities and threats faced by the vendors in the global hormone
replacement therapy market?
What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
What are the key outcomes of the five forces analysis of the global hormone replacement
therapy market?
We also offers customization on reports based on specific client requirement.
Companies Mentioned:
F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, Pfizer, Abbott Laboratories, Amgen, ANI
Pharmaceuticals, Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion,
QuatRx Pharmaceuticals, Teva Pharmaceutical Industries, TherapeuticsMD.
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We
have vast database of reports from the leading publishers and authors across the globe. We specialize in
delivering customized reports as per the requirements of our clients. We have complete information
about our publishers and hence are sure about the accuracy of the industries and verticals of their
specialization. This helps our clients to map their needs and we produce the perfect required market
research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Author
ruchishastri01
ruchishastri0116   documents Email
Document
Category
Health and Medicine
Views
89
File Size
387 KB
Tags
replacement
1/--pages
Report inappropriate content